Search Result

Results for "

LDL-oxidation

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Acyltransferase (2) Apoptosis (1) Bacterial (3) Caspase (1) Cholinesterase (ChE) (2) Drug Derivative (1) Drug Isomer (1) Drug Metabolite (2) Endogenous Metabolite (3) FOXO (1) Glutathione Peroxidase (1) HCV (1) HMG-CoA Reductase (HMGCR) (1) LDLR (2) NF-κB (1) Potassium Channel (1) Reactive Oxygen Species (ROS) (3) Reference Standards (2) Sirtuin (2) SOD (2) Tau Protein (2) UGT (2)
By Research Areas:	Cancer (4) Cardiovascular Disease (3) Infection (1) Inflammation/Immunology (8) Metabolic Disease (10) Neurological Disease (3)

Inhibitors & Agonists

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N0339

Syringic acid	Endogenous Metabolite Bacterial	Metabolic Disease
Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.

HY-N0521

(-)-Gallocatechin	Drug Isomer Reactive Oxygen Species (ROS)	Metabolic Disease Inflammation/Immunology Cancer
(-)-Gallocatechin, an epimer of (-)-Epigallocatechin (EGC) (HY-N0225), is contained in various tea products. (-)-Gallocatechin demonstrates antioxidant activity in vitro, including inhibition of LDL oxidation and DPPH radical scavenging .

HY-N0859

Schisanhenol Schizanhenol; Gomisin-K3	UGT Cholinesterase (ChE) Tau Protein SOD Sirtuin	Neurological Disease Inflammation/Immunology Cancer
Schisanhenol (Schizanhenol), a lignan, is an orally active antioxidant. Schisanhenol reduces AChE activity, increases SIRT1 and PGC-1α expression, and decreases phosphorylated Tau (Ser 396) levels. Schisanhenol increases SOD and glutathione peroxidase activity, decreases malondialdehyde (MDA) content, and inhibits UGT2B7 activitY. Schisanhenol attenuates ox-LDL-induced apoptosis, intracellular reactive oxygen species generation, and cytotoxicity in endothelial cells. Schisanhenol inhibits LDL oxidation, brain mitochondrial and membrane peroxidative damage, and brain mitochondrial swelling and disintegration. Schisanhenol can be used for the research of Alzheimer’s disease, atherosclerosis, brain ischemia, and age-related brain deterioration .

HY-113269

alpha-CEHC 1 Publications Verification	Drug Metabolite	Others
alpha-CEHC is a water-soluble metabolite of alpha-tocopherol (α-TOH) with potential antioxidant activity. alpha-CEHC slightly inhibits macrophage-induced low-density lipoprotein (LDL) oxidation, and its inhibitory potency is concentration-dependent .

HY-125039

N-Acetyl lysyltyrosylcysteine amide 2 Publications Verification	Glutathione Peroxidase	Cardiovascular Disease Neurological Disease
N-Acetyl lysyltyrosylcysteine amide is a potent, reversible, specific, and non-toxic tripeptide inhibitor of myeloperoxidase (MPO). N-Acetyl lysyltyrosylcysteine amide effectively inhibits MPO generation of toxic oxidants in vivo. N-Acetyl lysyltyrosylcysteine amide reduces neuronal damage and preserves brain tissue and neurological function in the stroked brain. N-Acetyl lysyltyrosylcysteine amide inhibits MPO-dependent hypochlorous acid (HOCl) generation, protein nitration, and LDL oxidation .

HY-N0339R

Syringic acid (Standard)	Reference Standards Endogenous Metabolite Bacterial	Metabolic Disease
Syringic acid (Standard) is the analytical standard of Syringic acid. This product is intended for research and analytical applications. Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.

HY-W778608

Quercetin 7-glucuronide 1 Publications Verification Quercetin 7-O-β-glucuronide	Drug Metabolite	Inflammation/Immunology
Quercetin 7-glucuronide (Quercetin 7-O-β-glucuronide), a metabolite of Quercetin (HY-18085), can be isolated from Madagascarian Uncarina species. Quercetin 7-glucuronide can inhibit LDL oxidation .

HY-120651

LDL-IN-2	LDLR	Metabolic Disease
LDL-IN-2 (compound 3) is an antioxidant against copper mediated low-density lipoproteins (LDL) oxidation .

HY-N3596

Cleomiscosin C Aquillochin	Others	Inflammation/Immunology
Cleomiscosin C (Aquillochin) can be isolated from Aquilaria agallocha. Cleomiscosin C has antioxidant activity. Cleomiscosin C inhibits LDL oxidation and free radicals generation .

HY-N10638

N-Acetyldopamine dimer-2	Reactive Oxygen Species (ROS) NF-κB	Inflammation/Immunology
N-Acetyldopamine dimer-2 (compound 2) is a N-acetyldopamine dimer that can be isolated from the yellow powder form Periostracum Cicadae with antioxidant and anti-inflammatory activities. N-Acetyldopamine dimer-2 inhibits oxidized low-density lipoprotein (LDL) oxidation, ROS generation, NO production, and NF-κB activity .

HY-N15706

Luteolin-7-O-β-D-glucuronide methyl ester	LDLR	Cardiovascular Disease Metabolic Disease
Luteolin-7-O-β-D-glucuronide methyl ester is a flavonoid with antioxidative activity. Luteolin-7-O-β-D-glucuronide methyl ester exhibits potent antioxidative activity with an IC₅₀ of 3.05 μg/mL in the NBT superoxide scavenging assay. Luteolin-7-O-β-D-glucuronide methyl ester inhibits LDL oxidation induced by Cu ²⁺ with the IC₅₀ value is 71.13 μg/mL .

HY-N0339S

Syringic acid-d6	Bacterial Endogenous Metabolite	Metabolic Disease
Syringic acid-d₆ is the deuterium labeled Syringic acid . Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation .

HY-119265

LDL-IN-4	Acyltransferase	Metabolic Disease
LDL-IN-4 (Compound 2) inhibits human acyl-CoA:cholesterol acyltransferase-1 and -2 activities. LDL-IN-4 inhibits copper-mediated low density lipoprotein (LDL) oxidation, with an IC₅₀ of 3 μM. LDL-IN-4 has anti-atherosclerotic biological activity .

HY-118486

LDL-IN-1	Acyltransferase	Metabolic Disease
LDL-IN-1 (Compound 1) is an antioxidant, and is active against copper mediated LDL oxidation (IC₅₀ = 52 μM). LDL-IN-1 is also an Acyl-CoA:cholesterol acyltransferase-1 and -2 (ACAT-1/2) inhibitor, with IC₅₀s of 60 μM. LDL-IN-1 can be used for anti-atherosclerotic research .

HY-137390A

(3S,5R)-Fluvastatin potassium	HMG-CoA Reductase (HMGCR)	Cardiovascular Disease Metabolic Disease
(3S,5R)-Fluvastatin (potassium) is a synthetic hypolipidemic drug that inhibits HMG-CoA reductase activity. (3S,5R)-Fluvastatin (potassium) has similar antioxidative effects on copper ion-induced LDL oxidation compared to its 3R,5S enantiomer. (3S,5R)-Fluvastatin (potassium) and its metabolites demonstrate a potential to exhibit anti-atherosclerotic effects through their antioxidative activities. (3S,5R)-Fluvastatin (potassium) is clinically utilized as part of a racemic mixture for reducing plasma cholesterol levels.

HY-N0859R

Schisanhenol (Standard) Schizanhenol (Standard); Gomisin-K3 (Standard)	UGT Reference Standards Cholinesterase (ChE) Tau Protein SOD Sirtuin	Neurological Disease Inflammation/Immunology Cancer
Schisanhenol (Standard) (Schizanhenol (Standard)) is the analytical standard of Schisanhenol (HY-N0859). This product is intended for research and analytical applications. Schisanhenol, a lignan, is an orally active antioxidant. Schisanhenol reduces AChE activity, increases SIRT1 and PGC-1α expression, and decreases phosphorylated Tau (Ser 396) levels. Schisanhenol increases SOD and glutathione peroxidase activity, decreases malondialdehyde (MDA) content, and inhibits UGT2B7 activitY. Schisanhenol attenuates ox-LDL-induced apoptosis, intracellular reactive oxygen species generation, and cytotoxicity in endothelial cells. Schisanhenol inhibits LDL oxidation, brain mitochondrial and membrane peroxidative damage, and brain mitochondrial swelling and disintegration. Schisanhenol can be used for the research of Alzheimer’s disease, atherosclerosis, brain ischemia, and age-related brain deterioration.

HY-106621A

AL 0671	Potassium Channel	Metabolic Disease
AL 0671 is a potassium channel opener. AL 0671 can inhibit nonenzymatic glycation of protein and LDL oxidation. AL 0671 can be used for the researches of cardiovascular and metabolic disease, such as hypertensive diabetes .

HY-N12385

Hispaglabridin B (R)-Hispaglabridin B	FOXO	Others
Hispaglabridin B is an anti-oxidant agent that can be isolated from Glycyrrhiza glabra. Hispaglabridin B exhibits potent peroxynitrite scavenging activity with an IC₅₀ of 3.2 μM, and shows activity in a low-density lipoprotein (LDL) oxidation system . Hispaglabridin B is also a FoxO1 inhibitor . Hispaglabridin B improves muscle wasting by inhibiting catabolism in vivo and in vitro.

HY-182603

BO-653	Drug Derivative Reactive Oxygen Species (ROS) HCV	Infection Inflammation/Immunology
BO-653 is an orally active anti-atherosclerotic antioxidant that exhibits high binding affinity for LDL. BO-653 scavenges linoleic acid peroxyl radicals, inhibits lipid peroxidation during the auto-oxidation of linoleic acid, and potently suppresses LDL oxidation. BO-653 inhibits Hepatitis C Virus (HCV) replication in a concentration-dependent manner, with an IC₅₀ of 36.0 μM against the HCV subgenomic replicon in FLR3-1 cells. BO-653 demonstrates significant anti-atherosclerotic effects in various animal models, including the Watanabe heritable hyperlipidemic rabbit. BO-653 is suitable for use in research related to atherosclerosis and Hepatitis C Virus infection .

HY-N11846

4′-O-Methylglabridin	Apoptosis Caspase	Inflammation/Immunology Cancer
4′-O-Methylglabridin is an apoptosis inducer with antioxidant, cell cycle-disrupting and anticancer cytotoxic activities. 4′-O-Methylglabridin inhibits various cancer cell lines including liver cancer, breast cancer and colorectal cancer cell lines. By reducing the expression levels of phosphorylated Rb (Ser807/811) and p21 proteins, 4′-O-Methylglabridin promotes cell accumulation at the subG1 and G2/M phases, and triggers caspase-dependent apoptosis via cytochrome C release and caspase-9 activation. 4′-O-Methylglabridin also exerts antioxidant effects by inhibiting lipid peroxide levels and reducing β-carotene consumption, thereby blocking *LDL* oxidation. 4′-O-Methylglabridin can be used in the research of various cancers and atherosclerotic diseases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N0339

Syringic acid	Monophenols Microorganisms other families Classification of Application Fields Phenols Metabolic Disease Plants Endogenous metabolite Disease Research Fields Source Classification	Endogenous Metabolite Bacterial
Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.

HY-N0521

(-)-Gallocatechin	Structural Classification Classification of Application Fields Metabolic Disease Camellia sinensis (L.) O. Ktze. Plants Flavonoids Flavanols Phenols Polyphenols Disease Research Fields Source Classification Theaceae Cancer	Drug Isomer Reactive Oxygen Species (ROS)
(-)-Gallocatechin, an epimer of (-)-Epigallocatechin (EGC) (HY-N0225), is contained in various tea products. (-)-Gallocatechin demonstrates antioxidant activity in vitro, including inhibition of LDL oxidation and DPPH radical scavenging .

HY-N0859

Schisanhenol Schizanhenol; Gomisin-K3	Structural Classification Monophenols Classification of Application Fields Lignans Phenols Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill. Disease Research Fields Source Classification Cancer	UGT Cholinesterase (ChE) Tau Protein SOD Sirtuin
Schisanhenol (Schizanhenol), a lignan, is an orally active antioxidant. Schisanhenol reduces AChE activity, increases SIRT1 and PGC-1α expression, and decreases phosphorylated Tau (Ser 396) levels. Schisanhenol increases SOD and glutathione peroxidase activity, decreases malondialdehyde (MDA) content, and inhibits UGT2B7 activitY. Schisanhenol attenuates ox-LDL-induced apoptosis, intracellular reactive oxygen species generation, and cytotoxicity in endothelial cells. Schisanhenol inhibits LDL oxidation, brain mitochondrial and membrane peroxidative damage, and brain mitochondrial swelling and disintegration. Schisanhenol can be used for the research of Alzheimer’s disease, atherosclerosis, brain ischemia, and age-related brain deterioration .

HY-113269

alpha-CEHC 1 Publications Verification	Microorganisms Source Classification	Drug Metabolite
alpha-CEHC is a water-soluble metabolite of alpha-tocopherol (α-TOH) with potential antioxidant activity. alpha-CEHC slightly inhibits macrophage-induced low-density lipoprotein (LDL) oxidation, and its inhibitory potency is concentration-dependent .

HY-N0339R

Syringic acid (Standard)	Structural Classification Monophenols Microorganisms other families Phenols Plants Endogenous metabolite Source Classification	Reference Standards Endogenous Metabolite Bacterial
Syringic acid (Standard) is the analytical standard of Syringic acid. This product is intended for research and analytical applications. Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation.

HY-W778608

Quercetin 7-glucuronide 1 Publications Verification Quercetin 7-O-β-glucuronide	Flavonols Flavonoids Pedaliaceae Plants Source Classification Uncarina grandidieri (Baill.) Ihlenf. & Straka	Drug Metabolite
Quercetin 7-glucuronide (Quercetin 7-O-β-glucuronide), a metabolite of Quercetin (HY-18085), can be isolated from Madagascarian Uncarina species. Quercetin 7-glucuronide can inhibit LDL oxidation .

HY-N3596

Cleomiscosin C Aquillochin	Thymelaeaceae Phenols Polyphenols Plants Aquilaria sinensis (Lour.) Spreng. Source Classification	Others
Cleomiscosin C (Aquillochin) can be isolated from Aquilaria agallocha. Cleomiscosin C has antioxidant activity. Cleomiscosin C inhibits LDL oxidation and free radicals generation .

HY-N15706

Luteolin-7-O-β-D-glucuronide methyl ester	Flavonoids Astragalus laxmannii Jacq. Flavones Labiatae Plants Source Classification	LDLR
Luteolin-7-O-β-D-glucuronide methyl ester is a flavonoid with antioxidative activity. Luteolin-7-O-β-D-glucuronide methyl ester exhibits potent antioxidative activity with an IC₅₀ of 3.05 μg/mL in the NBT superoxide scavenging assay. Luteolin-7-O-β-D-glucuronide methyl ester inhibits LDL oxidation induced by Cu ²⁺ with the IC₅₀ value is 71.13 μg/mL .

HY-N0859R

Schisanhenol (Standard) Schizanhenol (Standard); Gomisin-K3 (Standard)	Structural Classification Monophenols Lignans Phenols Phenylpropanoids Plants Schisandraceae Schisandra chinensis (Turcz.) Baill. Source Classification	UGT Reference Standards Cholinesterase (ChE) Tau Protein SOD Sirtuin
Schisanhenol (Standard) (Schizanhenol (Standard)) is the analytical standard of Schisanhenol (HY-N0859). This product is intended for research and analytical applications. Schisanhenol, a lignan, is an orally active antioxidant. Schisanhenol reduces AChE activity, increases SIRT1 and PGC-1α expression, and decreases phosphorylated Tau (Ser 396) levels. Schisanhenol increases SOD and glutathione peroxidase activity, decreases malondialdehyde (MDA) content, and inhibits UGT2B7 activitY. Schisanhenol attenuates ox-LDL-induced apoptosis, intracellular reactive oxygen species generation, and cytotoxicity in endothelial cells. Schisanhenol inhibits LDL oxidation, brain mitochondrial and membrane peroxidative damage, and brain mitochondrial swelling and disintegration. Schisanhenol can be used for the research of Alzheimer’s disease, atherosclerosis, brain ischemia, and age-related brain deterioration.

HY-N12385

Hispaglabridin B (R)-Hispaglabridin B	Structural Classification Natural Products Glycyrrhiza glabra Linn. Leguminosae Plants Source Classification	FOXO
Hispaglabridin B is an anti-oxidant agent that can be isolated from Glycyrrhiza glabra. Hispaglabridin B exhibits potent peroxynitrite scavenging activity with an IC₅₀ of 3.2 μM, and shows activity in a low-density lipoprotein (LDL) oxidation system . Hispaglabridin B is also a FoxO1 inhibitor . Hispaglabridin B improves muscle wasting by inhibiting catabolism in vivo and in vitro.

HY-N11846

4′-O-Methylglabridin	Structural Classification Natural Products Glycyrrhiza glabra Linn. Leguminosae Plants Source Classification	Apoptosis Caspase
4′-O-Methylglabridin is an apoptosis inducer with antioxidant, cell cycle-disrupting and anticancer cytotoxic activities. 4′-O-Methylglabridin inhibits various cancer cell lines including liver cancer, breast cancer and colorectal cancer cell lines. By reducing the expression levels of phosphorylated Rb (Ser807/811) and p21 proteins, 4′-O-Methylglabridin promotes cell accumulation at the subG1 and G2/M phases, and triggers caspase-dependent apoptosis via cytochrome C release and caspase-9 activation. 4′-O-Methylglabridin also exerts antioxidant effects by inhibiting lipid peroxide levels and reducing β-carotene consumption, thereby blocking *LDL* oxidation. 4′-O-Methylglabridin can be used in the research of various cancers and atherosclerotic diseases .

Cat. No.	Product Name	Chemical Structure

HY-N0339S

Syringic acid-d6
Syringic acid-d₆ is the deuterium labeled Syringic acid . Syringic acid is correlated with high antioxidant activity and inhibition of LDL oxidation .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.

LDL-oxidation

Inhibitors & Agonists

NaturalProducts

Isotope-Labeled Compounds

Natural
Products